following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv)..
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done..
.
the us is rapidly running out of landfill space.
the data also revealed 66% of trusts who replied had at least one cancer patient forced to wait over six months to start treatment, and 69% had a worse longest wait than in 2010..
.
helen was proud and extremely independent, but had a soft, elegant side to her..